Clinical Operations

Neurology studies are highly complex. Explore the following 4 key considerations to successfully manage and monitor neurology trials.

RECIST criteria is not always reported accurately, and variability in tumor response assessment may be disastrous for measuring true treatment effect. Here’s how your CRO can support more consistent RECIST reads.

What do you need to consider when managing/monitoring an immuno-oncology clinical trial? Download PharPoint’s fact book to learn more.

Ms. Will joins PharPoint as the company continues to grow and engage an increasing number of biotech and pharmaceutical clients seeking personalized attention, therapeutically aligned expertise, industry-best timelines, and decentralized study options.